ACOG Earnings Date: Nov 12, 2026 (Estimated) — Alpha Cognition Inc
NASDAQ · Healthcare · Biotechnology
Updated
When is ACOG's next earnings date?
Alpha Cognition Inc (ACOG) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.33 on revenue of $7.0M.
How did ACOG do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), Alpha Cognition Inc posted EPS of -$0.40 versus the -$0.39 estimate, a miss of 2.6%. Revenue was $6.1M against a $4.4M estimate. The stock's 1-day post-earnings move was +2.4%.
How much does ACOG stock move after earnings?
ACOG beat EPS estimates in 3 of its last 4 reported quarters. Over the last 5 reports the stock moved an average of 4.5% (up or down) in the day after earnings.
About Alpha Cognition Inc
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.39 | -0.40 | -2.56% | $6.1M | ❌ Miss | +2.43% | +11.36% | +0.93% |
| 2026-05-14 | Q1 2026 | -0.40 | -0.32 | +20.00% | $3.5M | ✅ Beat | +5.99% | +2.46% | +5.46% |
| 2026-03-26 | Q4 2025 | -0.32 | -0.30 | +6.25% | $2.8M | ✅ Beat | -4.87% | +11.98% | +20.41% |
| 2025-11-13 | Q3 2025 | -0.45 | -0.30 | +33.33% | $2.8M | ✅ Beat | -3.10% | -4.89% | -18.27% |
| 2024-11-15 | Q2 2024 | — | -0.31 | — | $0 | — | +6.15% | +6.52% | +3.92% |
| 2022-12-31 | — | -1.25 | — | — | — | — | — | — | |
| 2022-09-30 | — | -0.76 | — | — | — | — | — | — | |
| 2022-06-30 | — | -1.10 | — | — | — | — | — | — |
Showing last 8 quarters.
Revenue by segment & region
By region
FY2025 · $10.2M total · annual
| Segment | Share | Revenue | YoY |
|---|---|---|---|
| UNITED STATES | 66.5% | $6.8M | — |
| CHINA | 33.5% | $3.4M | — |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.